ENCODE tiling array analysis identifies differentially expressed annotated and novel 5′ capped RNAs in hepatitis C infected liver

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Folkers, Milan E ^a   Delker, Don A ^a,b   Maxwell, Christopher I ^a,b   Nelson, Cassie A ^a   Schwartz, Jason J ^a   Nix, David A ^b   Hagedorn, Curt H ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPPED RNA; INTERFERON REGULATORY FACTOR 1; POLYADENYLATED RNA; REGULATOR PROTEIN; SCATTER FACTOR RECEPTOR; TRIPARTITE MOTIF CONTAINING 22 PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOME ANALYSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; INTRON; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; TRANSCRIPTION REGULATION; UPREGULATION; CELL STRAIN HL 60; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HEPATITIS C VIRUS; INSTRUMENTATION; ISOLATION AND PURIFICATION; LIVER; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; SEQUENCE ANALYSIS;

HEPATITIS C VIRUS;

CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HELA CELLS; HEPACIVIRUS; HEPATITIS C; HL-60 CELLS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA CAPS; SEQUENCE ANALYSIS, RNA;

EID: 79951931345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014697     Document Type: Article

References (69)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.
2. Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, et al. (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112: 1923-1930.
3. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, et al. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194: 1639-1647.
4. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102: 3738-3743.
5. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362: 362-369.
6. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, et al. (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7: 673-679.
7. Sotiriou C, Pusztai L, (2009) Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800.
8. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
9. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
10. Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, et al. (2008) A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A 105: 19432-19437.
11. Bigger CB, Brasky KM, Lanford RE, (2001) DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75: 7059-7066.
12. Smith MW, Walters KA, Korth MJ, Fitzgibbon M, Proll S, et al. (2006) Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology 130: 179-187.
13. Chen L, Borozan I, Feld J, Sun J, Tannis LL, et al. (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444.
14. Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, et al. (2003) Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markers. Hepatology 38: 1458-1467.
15. Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, et al. (2006) Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J 3: 98.
16. Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, et al. (2006) Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 44: 1122-1138.
17. Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, et al. (2009) Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 10: 373.
18. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
19. Dutrow N, Nix DA, Holt D, Milash B, Dalley B, et al. (2008) Dynamic transcriptome of Schizosaccharomyces pombe shown by RNA-DNA hybrid mapping. Nat Genet 40: 977-986.
20. Choi YH, Hagedorn CH, (2003) Purifying mRNAs with a high-affinity eIF4E mutant identifies the short 3′ poly(A) end phenotype. Proc Natl Acad Sci U S A 100: 7033-7038.
21. Rasmussen EB, Lis JT, (1993) In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. Proc Natl Acad Sci U S A 90: 7923-7927.
22. Shatkin AJ, Manley JL, (2000) The ends of the affair: Capping and polyadenylation. Nat Struct Biol 7: 838-842.
23. Spivak-Kroizman T, Friedland DE, De Staercke C, Gernert KM, Goss DJ, et al. (2002) Mutations in the S4-H2 loop of eIF4E which increase the affinity for m7GTP. FEBS Lett 516: 9-14.
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
25. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, et al. (2003) GoMiner: A resource for biological interpretation of genomic and proteomic data. Genome Biol 4: R28.
26. Sumpter R Jr, Wang C, Foy E, Loo YM, Gale M Jr, (2004) Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J Virol 78: 11591-11604.
27. Barr SD, Smiley JR, Bushman FD, (2008) The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 4: e1000007.
28. Bo Gao, Zhijian Duan, Wei Xu, Sidong Xiong, (2009) Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 9999 NA.
29. Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, et al. (2009) Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat 16: 612-620.
30. Li K, Wang L, Cheng J, Zhang L, Duan H, et al. (2002) [Screening and cloning gene of hepatocyte protein interacting with hepatitis C virus core protein]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 16: 351-353.
31. Wu JQ, Du J, Rozowsky JS, Zhang ZD, Urban AE, et al. (2008) Systematic analysis of transcribed loci in ENCODE regions using RACE sequencing reveals extensive transcription in the human genome. Genome Biology 9: R3.
32. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, et al. (2007) Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Research 17: 746-759.
33. Richter JD, (2008) Breaking the code of polyadenylation-induced translation. Cell 132: 335-337.
34. Weber M, Hagedorn CH, Harrison DG, Searles CD, (2005) Laminar shear stress and 3′ polyadenylation of eNOS mRNA. Circ Res 96: 1161-1168.
35. Peng J, Schoenberg DR, (2005) mRNA with a <20-nt poly(A) tail imparted by the poly(A)-limiting element is translated as efficiently in vivo as long poly(A) mRNA. RNA 11: 1131-1140.
36. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, et al. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49: 1098-1112.
37. Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, et al. (2004) Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 78: 9713-9720.
38. Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, et al. (2006) Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13: 690-700.
39. Wietzke-Braun P, Maouzi AB, Manhardt LB, Bickeboller H, Ramadori G, et al. (2006) Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. Eur J Gastroenterol Hepatol 18: 991-997.
40. Nisole S, Stoye JP, Saib A, (2005) TRIM family proteins: Retroviral restriction and antiviral defence. Nat Rev Microbiol 3: 799-808.
41. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR, (2005) Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42: 702-710.
42. Brown D, Trowsdale J, Allen R, (2004) The LILR family: Modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64: 215-225.
43. Vlad G, Piazza F, Colovai A, Cortesini R, Della Pietra F, et al. (2003) Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum Immunol 64: 483-489.
44. Chang CC, Liu Z, Vlad G, Qin H, Qiao X, et al. (2009) Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol 182: 5208-5216.
45. Asselah T, Bieche I, Narguet S, Sabbagh A, Laurendeau I, et al. (2008) Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut 57: 516-524.
46. Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, et al. (2005) Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 332: 130-144.
47. Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, et al. (2005) Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 129: 2064-2075.
48. Mas VR, Fassnacht R, Archer KJ, Maluf D, (2010) Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 16: 287-297.
49. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW, (2002) Insights into the pathobiology of hepatitis C virus-associated cirrhosis: Analysis of intrahepatic differential gene expression. Am J Pathol 160: 641-654.
50. Hayashida K, Daiba A, Sakai A, Tanaka T, Kaji K, et al. (2005) Pretreatment prediction of interferon-alfa efficacy in chronic hepatitis C patients. Clin Gastroenterol Hepatol 3: 1253-1259.
51. Aparicio E, Parera M, Franco S, Perez-Alvarez N, Tural C, et al. (2010) IL28B SNP rs8099917 is strongly associated with pegylated interferon-alpha and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. PLoS One 5: e13771.
52. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
53. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
54. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
55. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
56. Dill MT, Duong FH, Vogt JE, Bibert S, Bochud PY, et al. (2010) Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response than IL28B Genotype in Patients with Hepatitis C. Gastroenterology.
57. Kikuchi K, Fukuda M, Ito T, Inoue M, Yokoi T, et al. (2009) Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res 37: 4987-5000.
58. Ritchie W, Theodule FX, Gautheret D, (2008) Mireval: A web tool for simple microRNA prediction in genome sequences. Bioinformatics 24: 1394-1396.
59. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: Tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
60. Beilharz TH, Humphreys DT, Clancy JL, Thermann R, Martin DI, et al. (2009) microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One 4: e6783.
61. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, et al. (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203: 2433-2440.
62. Suh N, Crittenden SL, Goldstrohm A, Hook B, Thompson B, et al. (2009) FBF and its dual control of gld-1 expression in the Caenorhabditis elegans germline. Genetics 181: 1249-1260.
63. Friedland DE, Wooten WN, LaVoy JE, Hagedorn CH, Goss DJ, (2005) A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides. Biochemistry 44: 4546-4550.
64. Bajak EZ, Hagedorn CH, (2008) Efficient 5′ cap-dependent RNA purification: Use in identifying and studying subsets of RNA. Methods Mol Biol 419: 147-160.
65. Nicol JW, Helt GA, Blanchard SG Jr, Raja A, Loraine AE, (2009) The Integrated Genome Browser: Free software for distribution and exploration of genome-scale data sets. Bioinformatics.
66. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
67. Birney E, Andrews TD, Bevan P, Caccamo M, Chen Y, et al. (2004) An overview of Ensembl. Genome Res 14: 925-928.
68. Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, et al. (2006) The UCSC Known Genes. Bioinformatics 22: 1036-1046.
69. Baldi P, Long AD, (2001) A Bayesian framework for the analysis of microarray expression data: Regularized t-test and statistical inferences of gene changes. Bioinformatics 17: 509-519.